Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.

Date
2014
Author
Coskun, Ugur
TONYALI, Onder
Kara, HASAN VOLKAN
BALVAN, Ozlem
EREN, Tulay
HELVACI, Kaan
Berk, Veli
DEMIRCI, Umut
Ozturk, Selcuk Cemil
DOGAN, Erkan
CETIN, Bulent
Kucukoner, Mehmet
TUFAN, Gulnihal
Oztop, Ilhan
GUMUS, Mahmut
Uner, Aytug
TURAN, Nedim
Benekli, Mustafa
DANE, FAYSAL
Ozet, Ahmet
Buyukberber, Suleyman
Unal, Olcun Umit
Tastekin, Didem
KOCA, Dogan
Metadata
Show full item record
Abstract
Introduction: We investigated the impact of modern chemotherapy regimens and bevacizumab following pulmonary metastasectomy (PM) from metastatic colorectal cancer (CRC).
URI
http://hdl.handle.net/20.500.12627/80892
https://doi.org/10.1111/1759-7714.12107
Collections